Evidence map›Paper›PMID 35231133›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2022

Biobased Elastomer Nanofibers Guide Light-Controlled Human-iPSC-Derived Skeletal Myofibers.

Aimee Cheesbrough, Fabiola Sciscione, Federica Riccio, Peter Harley, Lea R'Bibo, Georgios Ziakas, Arnold Darbyshire, Ivo Lieberam, Wenhui Song

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Nanofibrous filters: A promising solution for the efficient capture of polydisperse viral aerosols.Aerosol science and technology : the journal of the American Association for Aerosol Research · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles.International journal of molecular sciences · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aimee CheesbroughUCL Centre for Biomaterials in Surgical Reconstruction and Regeneration, Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London, NW3 2PF, UK.
Fabiola SciscioneUCL Centre for Biomaterials in Surgical Reconstruction and Regeneration, Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London, NW3 2PF, UK.
Federica RiccioCentre for Gene Therapy and Regenerative Medicine, MRC Centre for Neurodevelopmental Disorders, Centre for Developmental Neurobiology, Kings College London, London, SE1 9RT, UK.
Peter HarleyCentre for Gene Therapy and Regenerative Medicine, MRC Centre for Neurodevelopmental Disorders, Centre for Developmental Neurobiology, Kings College London, London, SE1 9RT, UK.
Lea R'BiboCentre for Gene Therapy and Regenerative Medicine, MRC Centre for Neurodevelopmental Disorders, Centre for Developmental Neurobiology, Kings College London, London, SE1 9RT, UK.
Georgios ZiakasUCL Centre for Biomaterials in Surgical Reconstruction and Regeneration, Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London, NW3 2PF, UK.
Arnold DarbyshireUCL Centre for Biomaterials in Surgical Reconstruction and Regeneration, Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London, NW3 2PF, UK.
Ivo LieberamCentre for Gene Therapy and Regenerative Medicine, MRC Centre for Neurodevelopmental Disorders, Centre for Developmental Neurobiology, Kings College London, London, SE1 9RT, UK.
Wenhui SongUCL Centre for Biomaterials in Surgical Reconstruction and Regeneration, Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London, NW3 2PF, UK.ORCID https://orcid.org/0000-0001-8406-472X

Funding

Biotechnology and Biological Sciences Research Council BB/M009513/1Medical Research Council MR/N025865/1Medical Research Council MR/N026063/1Medical Research Council MR/W006251/1
6 · The paper itself

Abstract

Generating skeletal muscle tissue that mimics the cellular alignment, maturation, and function of native skeletal muscle is an ongoing challenge in disease modeling and regenerative therapies. Skeletal muscle cultures require extracellular guidance and mechanical support to stabilize contractile myofibers. Existing microfabrication-based solutions are limited by complex fabrication steps, low throughput, and challenges in measuring dynamic contractile function. Here, the synthesis and characterization of a new biobased nanohybrid elastomer, which is electrospun into aligned nanofiber sheets to mimic the skeletal muscle extracellular matrix, is presented. The polymer exhibits remarkable hyperelasticity well-matched to that of native skeletal muscle (≈11-50 kPa), with ultimate strain ≈1000%, and elastic modulus ≈25 kPa. Uniaxially aligned nanofibers guide myoblast alignment, enhance sarcomere formation, and promote a ≈32% increase in myotube fusion and ≈50% increase in myofiber maturation. The elastomer nanofibers stabilize optogenetically controlled human induced pluripotent stem cell derived skeletal myofibers. When activated by blue light, the myofiber-nanofiber hybrid constructs maintain a significantly higher (>200%) contraction velocity and specific force (>280%) compared to conventional culture methods. The engineered myofibers exhibit a power density of ≈35 W m

Indexed as

Induced Pluripotent Stem CellsNanofibersCell DifferentiationElastomersHumansMuscle Fibers, SkeletalMuscle, SkeletalTissue EngineeringTissue ScaffoldsElastomersbiobased elastomer nanofiberselectrospinninghuman induced pluripotent stem cellsmyogenic differentiationoptogenetics

Identifiers

PMID35231133
PMCPMC9131876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.